Anandamide-loaded nanoparticles: Preparation and characterization

References

• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliv Rev 2006; 58: 1688–713
   PubMed Web of Science ®Google Scholar
• Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. Pharmacological and behavioural evaluation of alkylated anandamide analogs. Life Sci 1995; 56: 2041–8
   PubMed Web of Science ®Google Scholar
• Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno A, Zhang L, Pridgen E, Wang A, Molnar S, Westerhof K, Farokhzad OC. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. Chem Med Chem 2008; 3: 1839–43
   Google Scholar
• Bendels S, Tsinman O, Wagner B, Lipp D, Parrilla I, Kansy M, Avdeef A. PAMPA-excipient classification gradient map. Pharm Res 2006; 23: 2525–35
   PubMed Web of Science ®Google Scholar
• Bojesen IN, Hansen HS. Binding of anandamide to bovine serum albumin. J Lipid Res 2003; 44: 1790–4
   PubMed Web of Science ®Google Scholar
• Bojesen IN, Hansen HS. Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 2005; 46: 1652–9
   PubMedGoogle Scholar
• Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP, Marciano-Cabral F. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci 1995; 56: 2065–72
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly-(ϵ-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127–38
   PubMed Web of Science ®Google Scholar
• Crescenze V, Manzini G, Calzolari G, Borri C. Thermodynamics of fusion of poly β-propiolactone and poly ϵ-caprolactone. Comparative analysis of the melting of aliphatic polylactone and polyester chains. Eur Polym J 1972; 8: 449–63
   Google Scholar
• Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 946–9
   Google Scholar
• De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. PNAS USA 1998; 95: 8375–80
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 2006; 116: 1–27
   PubMed Web of Science ®Google Scholar
• Di Pasquale E, Chahinian H, Sanchez P, Fantini J. The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent. PLoS ONE 2009; 4: e4989
   Google Scholar
• Dong XW, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res 2009; 69: 3918–26
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55: S1–4
   Web of Science ®Google Scholar
• Garret ER, Hunt A. Physicochemical properties, solubility, and protein binding of Δ9-tetrahydrocannabinol. J Pharm Sci 1974; 63: 1056–64
   PubMedGoogle Scholar
• Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG. Evidence against the presence of anandamide transporter. PNAS 2003; 100: 4269–74
   PubMed Web of Science ®Google Scholar
• Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: A critical review. Life Sci 2005; 77: 1584–604
   PubMed Web of Science ®Google Scholar
• Hernán D, Molpeceres J, Aberturas MR, Martin C, Gil ME, Torres AI, 2009. Determinación de la solubilidad y de la compatibilidad principio activo-excipiente para el desarrollo de microesferas como sistemas de liberación prolongada de cannabinoides, IX Congreso SEFIG, Pamplona, pp. 193–4
   Google Scholar
• Jarho P, Urtti A, Järvinen K, Pate DW, Järvinen T. Hydroxypropyl-ß-cyclodextrin increases aqueous solubility and stability of anandamide. Life Sci 1996b; 58: 181–5
   Google Scholar
• Jarho P, Urtti A, Pate DW, Suhonen P, Järvinen T. Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-ß-cyclodextrin. Int J Pharm 1996a; 137: 209–16
   Web of Science ®Google Scholar
• Joshi M, Misra A. Dry powder inhalation of liposomal ketotifen fumarate: Formulation and characterization. Int J Pharm 2001; 223(1,2)15–27
   PubMedGoogle Scholar
• Juntunen J, Huuskonen J, Laine K, Niemi R, Taipale H, Nevalainen T, Pate DW, Jarvinen T. Anandamide prodrugs - 1. Water-soluble phosphate esters of arachidonylethanolamide and R-methananda. Eur J Pharm Sci 2003; 19: 37–43
   PubMedGoogle Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces 2010; 75(1)1–18
   PubMed Web of Science ®Google Scholar
• Li S-D, Huang L. Pharmacockinetics and biodistribution of nanoparticles. Mol Pharm 2008; 5: 496–504
   PubMed Web of Science ®Google Scholar
• Ligresti A, De Petrocellis L, Hernán Pérez de la Ossa D, Aberturas MR, Cristino L, Moriello AS, Finizio A, Gil ME, Torres AI, Molpeceres J, et al. Exploiting nanotechnologies and TRPV-1 channels to investigate the putative anandamide membrane transporter. PLoS ONE 2010; 5(4)e10239
   Google Scholar
• Liu H, Sabus C, Carter GT, Du C, Avdeef A, Tischler M. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection. Pharm Res 2003; 20: 1820–6
   PubMed Web of Science ®Google Scholar
• Passerini N, Albertini B, Gonzalez-Rodriguez M, Cavallari C, Rodriguez L. Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci 2002; 15: 71–8
   PubMed Web of Science ®Google Scholar
• Pate DW, Järvinen K, Urtti A, Jarho P, Mahadevan V, Järvinen T. Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. Pharm Res 1997; 14: 1738–43
   PubMedGoogle Scholar
• Perera G, Greindl M, Palmberger TF, Bernkop-Schnurch A. Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine. Drug Deliv 2009; 16: 254–60
   PubMed Web of Science ®Google Scholar
• Shah L, Amiji MM. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Pharm Res 2006; 23: 2638–45
   PubMed Web of Science ®Google Scholar
• Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 1994; 270: 219–27
   PubMed Web of Science ®Google Scholar
• Song XR, Zhao Y, Hou SX, Xu FY, Zhao R, He JY, Cai Z, Li YB, Chen QH. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2008; 69: 445–53
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Anandrao R, Kulkarni AR, Rudzinsk WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Van Vlerken LE, Duan Z, Seiden MV, Amiji MM. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007; 67: 4843–50
   PubMed Web of Science ®Google Scholar
• Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 2007; 59: 718–28
   PubMed Web of Science ®Google Scholar
• Wenger T, Toth BE, Martin BR. Effects of anandamide (endogenous cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci 1995; 56: 2057–63
   PubMedGoogle Scholar
• Zhang J, Jiang W, Zhao X, Wang Y. Preparation and characterization of polymeric micelles from poly (D,L lactide) and methoxypolyethylene glycol block copolymers as potential drug carriers. Tsinghua Sci Technol 2007; 12: 493–6
   Google Scholar
• Zhu C, Jiang L, Chen TM, Hwang KK. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem 2002; 37: 399–407
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Muller RH, Madder K. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 2000; 196: 211–13
   PubMed Web of Science ®Google Scholar